Last updated on May 2020

Study of TSR-042 an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody in Participants With Advanced Solid Tumors


Brief description of study

This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (also known as TSR-042) n participants with advanced solid tumors who have limited available treatment options. The study will be conducted in 2 parts with Part 1 consisting of safety evaluation, pharmacokinetics (PK), and pharmacodynamics (PDy) of escalating doses of dostarlimab. Dose escalation will be based on ascending weight-based dose levels (DLs) of dostarlimab and will continue until the maximum tolerated dose (MTD) is reached or may be stopped at any dose level up to the highest dose of 20 milligrams per kilograms (mg/kg) based on emerging safety and PK/PDy data. Part 2 will be conducted in two subparts, Part 2A (fixed-dose safety evaluation cohorts) and Part 2B (expansion cohorts). Part 2A of the study will evaluate the safety and tolerability of dostarlimab at fixed doses of 500 mg administered every 3 weeks (Q3W) and 1000 mg administered every 6 weeks (Q6W). Part 2B of the study will examine the safety and clinical activity of dostarlimab in cohorts of participants with specific types of advanced solid tumors.

Clinical Study Identifier: NCT02715284

Find a site near you

Start Over

US GSK Clinical Trials Call …

Birmingham, AL United States
  Connect »

US GSK Clinical Trials Call …

Scottsdale, AZ United States
  Connect »

US GSK Clinical Trials Call …

Fayetteville, AR United States
  Connect »

US GSK Clinical Trials Call …

Los Angeles, CA United States
  Connect »

US GSK Clinical Trials Call …

Newport Beach, CA United States
  Connect »

US GSK Clinical Trials Call …

San Francisco, CA United States
  Connect »

US GSK Clinical Trials Call …

Santa Monica, CA United States
  Connect »

US GSK Clinical Trials Call …

Washington, WA United States
  Connect »

US GSK Clinical Trials Call …

Jacksonville, FL United States
  Connect »

US GSK Clinical Trials Call …

Scarborough, ME United States
  Connect »

US GSK Clinical Trials Call …

Kansas City, MO United States
  Connect »

US GSK Clinical Trials Call …

Farmington, NM United States
  Connect »

US GSK Clinical Trials Call …

Oklahoma City, OK United States
  Connect »

US GSK Clinical Trials Call …

Philadelphia, PA United States
  Connect »

US GSK Clinical Trials Call …

Providence, RI United States
  Connect »

US GSK Clinical Trials Call …

San Antonio, TX United States
  Connect »

US GSK Clinical Trials Call …

Salt Lake City, UT United States
  Connect »

US GSK Clinical Trials Call …

Charlottesville, VA United States
  Connect »

US GSK Clinical Trials Call …

Morgantown, WV United States
  Connect »

US GSK Clinical Trials Call …

Santiago De Compostela, Spain
  Connect »

US GSK Clinical Trials Call …

Newcastle Upon Tyne, United Kingdom
  Connect »

GSK Investigational Site

Birmingham, AL United States
  Connect »

GSK Investigational Site

Goodyear, AZ United States
  Connect »

GSK Investigational Site

Phoenix, AZ United States
  Connect »

GSK Investigational Site

Scottsdale, AZ United States
  Connect »

GSK Investigational Site

La Jolla, CA United States
  Connect »

GSK Investigational Site

Los Angeles, CA United States
  Connect »

GSK Investigational Site

Newport Beach, CA United States
  Connect »

GSK Investigational Site

Orange, CA United States
  Connect »

GSK Investigational Site

San Francisco, CA United States
  Connect »

GSK Investigational Site

Santa Monica, CA United States
  Connect »

GSK Investigational Site

Jacksonville, FL United States
  Connect »

GSK Investigational Site

Miami, FL United States
  Connect »

GSK Investigational Site

Tampa, FL United States
  Connect »

GSK Investigational Site

Atlanta, GA United States
  Connect »

GSK Investigational Site

Augusta, GA United States
  Connect »

GSK Investigational Site

Chicago, IL United States
  Connect »

GSK Investigational Site

Westwood, KS United States
  Connect »

GSK Investigational Site

Scarborough, ME United States
  Connect »

GSK Investigational Site

Baltimore, MD United States
  Connect »

GSK Investigational Site

Boston, MA United States
  Connect »

GSK Investigational Site

Detroit, MI United States
  Connect »

GSK Investigational Site

Rochester, MN United States
  Connect »

GSK Investigational Site

Kansas City, MO United States
  Connect »

GSK Investigational Site

Albany, NY United States
  Connect »

GSK Investigational Site

Brooklyn, NY United States
  Connect »

GSK Investigational Site

New York, NY United States
  Connect »

GSK Investigational Site

Charlotte, NC United States
  Connect »

GSK Investigational Site

Cleveland, OH United States
  Connect »

GSK Investigational Site

Columbus, OH United States
  Connect »

GSK Investigational Site

Oklahoma City, OK United States
  Connect »

GSK Investigational Site

Portland, OR United States
  Connect »

GSK Investigational Site

Philadelphia, PA United States
  Connect »

GSK Investigational Site

Providence, RI United States
  Connect »

GSK Investigational Site

Nashville, TN United States
  Connect »

GSK Investigational Site

Dallas, TX United States
  Connect »

GSK Investigational Site

Houston, TX United States
  Connect »

GSK Investigational Site

San Antonio, TX United States
  Connect »

GSK Investigational Site

Charlottesville, VA United States
  Connect »

GSK Investigational Site

Seattle, WA United States
  Connect »

GSK Investigational Site

Spokane, WA United States
  Connect »

GSK Investigational Site

Morgantown, WV United States
  Connect »

GSK Investigational Site

Milwaukee, WI United States
  Connect »

GSK Investigational Site

Marseille Cedex 9, France
  Connect »

GSK Investigational Site

Villejuif Cedex, France
  Connect »

GSK Investigational Site

Santiago de Compostela, Spain
  Connect »

GSK Investigational Site

Aberdeen, United Kingdom
  Connect »

GSK Investigational Site

Headington, Oxford, United Kingdom
  Connect »

GSK Investigational Site

Newcastle upon Tyne, United Kingdom
  Connect »

GSK Investigational Site

Fayetteville, AR United States
  Connect »

GSK Investigational Site

Salt Lake City, UT United States
  Connect »

GSK Investigational Site

Encinitas, CA United States
  Connect »

GSK Investigational Site

Washington, WA United States
  Connect »

GSK Investigational Site

Farmington, NM United States
  Connect »

GSK Investigational Site

Jamaica, NY United States
  Connect »

GSK Investigational Site

Hilliard, OH United States
  Connect »

GSK Investigational Site

Spokane Valley, WA United States
  Connect »

GSK Investigational Site

Manchester, United Kingdom
  Connect »